rss
Postgrad Med J 2002;78:727-731 doi:10.1136/pmj.78.926.727
  • Review

Monitoring hormone replacement therapy by biochemical markers of bone metabolism in menopausal women

  1. E Dogan,
  2. C Posaci
  1. Dokuz Eylul University Faculty of Medicine, Department of Obstetrics and Gynaecology, Izmir, Turkey
  1. Correspondence to:
 Dr Erbil Dogan, Dokuz Eylul Universitesi Tip Fakultesi, Kadin Hastaliklari ve Dogum Anabilim Dali, Inciralti/Izmir 35340, Turkey;
 erbil.dogan{at}deu.edu.tr
  • Received 28 March 2002
  • Accepted 10 September 2002

Abstract

Biochemical markers of bone metabolism are divided into two groups: formation and resorption markers. Bone turnover is a dynamic process, which increases in postmenopausal period. Hormone replacement therapy (HRT) can diminish this increased bone turnover. Biochemical markers reflect acute changes in bone metabolism. Therefore, they may be very useful for the prediction of subsequent bone mineral density changes after HRT in menopausal women. Both oral and transdermal routes of HRT are efficacious in decreasing the levels of biochemical markers. However, markers do not replace bone mineral density measurement. Collagen type I cross linked N-telopeptide, collagen type I cross linked C-telopeptide, and osteocalcin are the most promising markers.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.